Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,040 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page
25
Current page
18
8-K File 001-35890

8-K

Filing date
22 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-228209

424B3

Filing date
20 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87213

NEW ENTERPRISE ASSOCIATES 15, L.P. - MILLENDO THERAPEUTICS, INC. 13D

Filing date
18 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G filing

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
13 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87213

SC 13D

Filing date
13 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Dec 2018
Reporting date
07 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .